CLINICAL_TRIALS
trial_result
· 2019-03-05
Clinical Trial Update: Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis [Phase 2]
Summary
Phase 2 trial assessing serlopitant for pruritus in adults with atopic dermatitis completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Vyne Therapeutics Inc. | Conditions: Pruritus, Atopic Dermatitis | Phase 2 | Status: COMPLETED | Results posted: 2019-03-05